Healthcare - The Biggest Scam in America
- 6 days ago
- 3 min read
10 Reasons the U.S. Healthcare System Is a ScamIn the classic board game Monopoly, landing on a high-rent property is just a temporary setback—pay up and keep rolling. But in real life, the American healthcare system isn’t a game. It’s a massive, profit-driven industry where getting sick is bad… but the bills? Those pay. Hospitals, insurers, pharmaceutical companies, device makers, and contractors all have financial stakes in keeping the revenue flowing. Today we break down 10 reasons the U.S. healthcare system shifted from a care-focused institution to something that looks a lot more like a financial extraction machine dressed in scrubs.
#10: No Transparency, Just Vibes
Try to find out how much a procedure costs before you get it. There is no menu. This is one of the only major industries where customers routinely cannot learn the price in advance. Want to know what your surgery will cost? You’ll get a bill later that can land anywhere between a used car and a house down payment—and surprise, you may still owe more after “facility fees” and other mystery line items appear.
#9: Hospital Bills Straight Out of Fantasyland
Hospitals routinely mark up prices far beyond what the same items cost outside their walls. An IV bag that costs roughly $10 at a pharmacy can appear on a hospital bill for hundreds of dollars, plus additional charges. Bills can run into the tens or hundreds of thousands for short stays, and even basic items show extreme markups. When a third party (insurance or government) is paying most of the tab, the incentive to scrutinize every charge weakens—and prices stay high.
#8: Insurance Is Just a Fancy Word for “Maybe”
You pay substantial monthly premiums for the privilege of still facing a multi-thousand-dollar deductible and co-pays every time you see a doctor. Go out of network and the bills can look like ransom notes. For many people, coverage functions less like a reliable safety net and more like a system that still leaves them exposed to large unexpected costs.
#7: Insurance Companies Have a Hobby—It’s Called “Denying Your Claim”
Insurers often profit more when they pay less. Doctors recommend treatment; the company may respond with delays, denials, or repeated requests for more information. Stories of patients needing multiple appeals before approval are common. Claims adjusters exist in part to evaluate (and frequently limit) what gets paid.
#6: Big Pharma’s Favorite Game—Price Gouge Roulette
The same life-saving drug can cost dramatically more in the United States than in other countries. American patients and taxpayers effectively subsidize a large share of global pharmaceutical research and development costs. Prices for older drugs have also risen sharply over time in ways that appear driven more by market power and policy than pure supply and demand.
#5: Lobbying—The Real National Health Plan
Pharmaceutical and insurance interests spend billions on lobbying. That money is not spent for charity. It helps shape the rules under which they operate. Revolving doors between industry and regulatory agencies raise ongoing questions about independence and whose interests are prioritized.
#4: Doctors: Healers or Salespeople?
Some physicians receive incentives—trips, meals, consulting arrangements, or other perks—linked to prescribing or using certain products. Although anti-kickback laws exist, creative workarounds persist. The result can be prescriptions or device choices influenced by factors beyond pure medical necessity.
#3: Emergency Room? More Like Emergency Wallet Drain
You arrive in crisis. Network status and pricing are rarely the first conversation. Facility fees, imaging, and short visits can generate four- or five-figure bills weeks later. The emergency department functions as both a safety net and a high-cost revenue center.
#2: The Secret World of Medical Device Kickbacks
When a hip, knee, pacemaker, or other implant is needed, the device chosen is not always selected solely on clinical superiority. Relationships between device companies and physicians—consulting fees, grants, stock options, or other benefits—can influence decisions. Higher-cost options can increase overall system expenses that ultimately flow back to patients and premium payers.
#1: Spin the Wheel, Determine the Price
Walk into a car dealership and ask the price of a vehicle; they do not first demand to see your insurance card. In healthcare, the amount charged frequently depends on who you are, what coverage you have, and the negotiated rates for that specific payer. One patient may pay a few hundred dollars for a service while another pays tens of thousands for the same care. Providers still get paid; the variation lands on the individual.
Final Thoughts
The healthcare system has legitimate goals—treating illness, preventing disease, and saving lives. But when profit motives dominate pricing, coverage decisions, product selection, and policy influence, incentives can shift away from efficiency and patient-centered outcomes toward sustaining high revenue. Meaningful reform discussions should focus on genuine price transparency, reduced administrative waste, better alignment of incentives, and limiting the financial conflicts that drive costs upward.What do you think? Is the system “working as designed” for some stakeholders? Drop your thoughts in the comments.
Comments